Abstract
This study aimed to assess the serum levels of intracellular adhesion molecule (sICAM-1), and vascular cell adhesion molecule (sVCAM-1), in the first psychotic episode schizophrenia (SZ) patients, before and after six months of antipsychotic treatment. The study included 50 patients with a first hospitalization for SZ and 50 healthy control subjects that were patient-matched regarding age, gender, body mass index and smoking status. The evaluation included the presence of cardiovascular risk factors, measurements of systolic and diastolic blood pressure, body mass index, smoking status, ankle-brachial index, carotid intima-media thickness, and echocardiography. The Brief Psychiatric Rating Scale (BPRS) score was calculated for the patients. The plasma levels of fasting glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, sICAM-1 and sVCAM-1 were determined at baseline in all subjects and after six months of antipsychotic treatment. Thirty patients (60%) were treated with olanzapine and 20 (40%) with risperidone. The average age of patients experiencing their first episode of SZ was 29.7±6.6 years, and 23 (46%) were men. The initial sICAM-1 levels of the patients were lower than those of the control group...Continue Reading
References
Aug 1, 1993·The Journal of Experimental Medicine·W A MullerD M Phillips
Jun 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·P MartellettiM Giacovazzo
Jan 29, 2000·Biological Psychiatry·M J SchwarzN Müller
Jun 19, 2002·Circulation·Lukas E SpiekerGeorg Noll
Sep 27, 2002·European Heart Journal·N T MulvihillM Walsh
Jul 5, 2005·Psychiatry Research·Dawn VelliganStephen Shon
Dec 27, 2005·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Roberto M LangUNKNOWN European Association of Echocardiography
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Nov 10, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Cecília AttuxAna Cristina Chaves
Dec 18, 2007·Schizophrenia Research·Laura FialkoDaniel Freeman
Nov 11, 2008·Schizophrenia Research·Rocio Perez-IglesiasBenedicto Crespo-Facorro
Jul 31, 2009·Biological Psychiatry·Jonathan M MeyerJeffrey A Lieberman
Jan 7, 2010·The Australian and New Zealand Journal of Psychiatry·Hung-Chuan LinHerng-Ching Lin
Apr 23, 2010·Journal of Clinical Pharmacology·Parminder S ChaggarSimon G Williams
Aug 19, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Pornpoj Pramyothin, Lalita Khaodhiar
Mar 13, 2012·Psychological Medicine·M LahtiJ Eriksson
Oct 22, 2013·Neuropsychiatric Disease and Treatment·Cüneyt UnsalErhan Kurt
Dec 3, 2013·Canadian Journal of Physiology and Pharmacology·Sawsan Aboul-Fotouh, Nesreen Elgayar
Apr 8, 2014·Schizophrenia Research·Rachel UpthegroveNicholas M Barnes
Mar 12, 2015·Schizophrenia Bulletin·Guillaume FondMarion Leboyer
Sep 12, 2015·The Lancet. Psychiatry·Golam M KhandakerPeter B Jones
Feb 24, 2016·Molecular Psychiatry·D R GoldsmithB J Miller
Mar 19, 2016·Psychopharmacology·Marion LeboyerLaurent Groc
Nov 28, 2016·Archives of Psychiatric Nursing·Sunny Chieh Cheng, Karen G Schepp
Sep 25, 2017·European Archives of Psychiatry and Clinical Neuroscience·Tanya T NguyenLisa T Eyler
Sep 1, 2018·Schizophrenia Bulletin·David FraguasCelso Arango
Oct 13, 2018·Tissue & Cell·Khaled Habas, Lijun Shang
Nov 9, 2018·Schizophrenia Bulletin·Toby PillingerOliver D Howes
Feb 19, 2019·Neuropsychiatric Disease and Treatment·Minodora AndorMirela Tomescu